Brief: Xspray Pharma Q1 Loss Before Tax Widens To SEK 34,8 Mln
04/05/2023 07:20
May 4 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* Q1 LOSS BEFORE TAX AMOUNTED TO SEK -34,827 THOUSAND
(-18,934)
Source text for Eikon: ID:nMFN185ww0
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003